SEOUL, Feb. 23 (Korea Bizwire) — South Korea’s drug safety agency on Wednesday authorized the use of global pharmaceutical giant Pfizer Inc.’s COVID-19 vaccine for children aged between 5 and 11. The Ministry of Food and Drug Safety convened a panel of experts from both inside and outside to review the safety and efficacy of [...]
SEOUL, Feb. 22 (Korea Bizwire) — South Korean pharmaceutical giant Celltrion Inc. said Tuesday that a high-concentration version of its autoimmune disease biosimilar Yuflyma has won approval from European drug authorities. The European Medicines Agency (EMA) gave the green light to Celltrion’s application to sell Yuflyma — a biosimilar referencing blockbuster drug Humira by AbbVie [...]
SEOUL, Feb. 22 (Korea Bizwire) — South Korea’s leading botox maker Hugel Inc. said Tuesday its botulinum toxin product, Letybo, has won approval from Austrian drug authorities. The Austrian Federal Office for Safety in Health Care granted the use of Letybo for the treatment of frown lines in adult patients. It marks the first time [...]
SEOUL, Feb. 22 (Korea Bizwire) — 8 out of 10 patients who took Paxlovid, a pill against COVID-19 developed by Pfizer Inc., showed improvements in their symptoms, health authorities said Monday. The Central Disease Control Headquarters unveiled the analytical results of the treatment of 364 virus patients who took Paxlovid. Of the total, 352 patients [...]
SEOUL, Feb. 21 (Korea Bizwire) — After the government temporarily lifted regulations on online medical diagnosis and treatments amid the COVID-19 pandemic, competition is heating up among new players to get the upper hand in the online medical connectivity market. Goodoc, a search/reservation service for medical services in the country, saw its monthly active users [...]
SEOUL, Feb. 18 (Korea Bizwire) — Samsung Bioepis Co., a South Korean biopharmaceutical company, said Friday that global sales of its five biosimilar products, outside of the South Korean market, jumped 11 percent on-year in 2021. The combined sales of the five biosimilars — Infliximab, Etanercept, Adalimumab, Trastuzumab and Bevacizumab — came to around US$1.25 [...]
GWANGJU, Feb. 18 (Korea Bizwire) — A campus startup operating under the umbrella of a South Korean university has developed a new method as an alternative to COVID-19 nasal swab testing. The method enables a relatively painless collection of specimens without giving for those who take COVID-19 tests. BIO3S from Chonnam National University said Thursday [...]
SEOUL, Feb. 16 (Korea Bizwire) — People living in areas with high levels of fine dust and other air pollutants are exposed to a higher risk of hearing disorders, a study showed Tuesday. A research team from Gachon University Gil Medical Center collected hearing test results for 15,051 people who participated in the 2010-2012 National [...]
SEOUL, Feb. 16 (Korea Bizwire) — Celltrion Inc., a major South Korean biopharmaceutical firm, said Wednesday that its net profit jumped 20.1 percent on-year last year on the back of robust sales of its biosimilar products in overseas markets. Net profit came to 623.7 billion won (US$521.1 million) last year on a consolidated basis, compared [...]
SEOUL, Feb. 15 (Korea Bizwire) — South Korean drug companies are upping the ante to develop the country’s first homegrown COVID-19 vaccine, possibly effective against the omicron variant, which may become a game changer in fighting the yearslong pandemic. According to the latest data by the Ministry of Food and Drug Safety, a total of [...]